Almost half of the EU vaping market is irregular as Brussels reworks tobacco rules

Half a market outside the rules

Almost half of the vaping products sold in the European Union are irregular, meaning they fall outside the bloc's framework for nicotine products. The estimate sets the backdrop for the reform of European tobacco and nicotine legislation now being prepared in Brussels, in a market that has changed considerably faster than the law written to govern it.

Irregularity is not a single offence. It covers devices and liquids never notified to national authorities, products whose nicotine strength, capacity or flavour profile is not permitted, items sold without the required health warnings and traceability, and goods that crossed a border without excise or customs clearance. The commercial effect is identical in every case. A non-compliant product reaches the shelf at a lower cost than a compliant one because it skips the testing, notification, labelling and tax that the compliant version has already paid for. That cost gap, not consumer preference, is what keeps a parallel market alive at this scale.

Two objectives pulling in different directions

The reform has to reconcile two goals that do not automatically reinforce each other: protecting public health as new nicotine products proliferate, and containing an illicit trade that is already expanding. Tighter product specifications, flavour restrictions and higher fiscal pressure reduce the appeal of the legal category, but they do nothing on their own to shrink the illegal one. Where a legal product disappears from the shelf, an untaxed substitute is usually already available through informal channels, online marketplaces and cross-border consignments. The tighter the legal envelope, the larger the arbitrage available to whoever ignores it.

• Manufacturers: product specifications, notification duties and flavour rules will determine which portfolios survive the transition and which have to be withdrawn.
• Importers and distributors: supply and customs risk rises as scrutiny of non-EU supply chains increases, with seizures and detention times becoming an operational cost.
• Retail: specialist vape shops and convenience channels carry the regulatory risk at the counter, alongside a price disadvantage against non-compliant competitors on the same street.
• National treasuries: no excise or VAT is collected on the irregular half of the market, so the fiscal case for reform is as strong as the health case.

Enforcement is the bottleneck, not drafting

The scale of the irregular segment reframes what success means for the reform. Harmonised rules on ingredients, packaging and flavours can be drafted centrally, but they are applied by national customs, market surveillance and tax authorities whose capacity and priorities differ across member states. A single-market rulebook enforced unevenly produces exactly the outcome visible today: compliance concentrated among larger, traceable operators and evasion concentrated among small, mobile ones.

For industry, the practical question is how much of the irregular half can be pulled back into the taxed market, and how quickly. Compliant producers have already absorbed the cost of testing, registration and labelling; every month the parallel channel keeps its price advantage is a month of transferred volume and margin. Investors assessing the sector face the same arithmetic in reverse, since reported category growth in the European Union reflects only the declared side of a market whose other half is not measured. Until enforcement closes part of that gap, projections built on legal sales alone will understate demand and overstate the addressable share available to regulated operators.